What is RSS?

In a world staggering under the weight of billions of web pages and cluttered email inboxes, keeping up to date with the latest pharmaceutical and medical device information you want can be hard.

Wouldn't it be better to have the latest information delivered directly to you, rather than clicking from site to site or fighting through unwanted pages of email? Well now you can, thanks to a very clever service, RSS.

There is some discussion as to what RSS stands for, but the majority go for 'Really Simple Syndication'. Put plainly, it allows you to identify the content you like and have it delivered directly to you.

It takes the hassle out of staying up to date, by giving you the very latest information in a format you want, when you want it.

Why use it?

• It's 100% opt-in, meaning you only receive the content you want and you can easily remove any feed when you don't want it anymore
• It requires no email address and is not delivered to your inbox
• You get content exactly at the time it's added to the content feed
• Content actually gets through and cannot be blocked by various filters.
• It is virus, trojan and other dangerous content free.

How do I start using RSS feeds?

In general, the first thing you need is something called a newsreader. There are many different versions, some of which are accessed using a browser, and some of which are downloadable applications. All allow you to display and subscribe to the RSS feeds you want.

You can subscribe to the feed in various ways, including by dragging the URL of the RSS feed into your news reader or by cutting and pasting the same URL into a new feed in your news reader.

Some browsers, including Firefox, Opera and Safari, have functionality which automatically picks up RSS feeds for you. For more details on these, please check their websites.

How do I get a newsreader?

There is a range of different newsreaders available and new versions are appearing all the time.

Different newsreaders work on different operating systems, so you will need to take this into account when you make your choice.

Using FDAnews RSS feeds on your site

We reserve the right to prevent the distribution of FDAnews content. Please read our Terms and Conditions for further instructions.

FDAnews does not accept any liability for its RSS feeds. Please see the Terms and Conditions for full details

News feeds by topic:	Copy URLs to RSS Reader
RxTi - RxTrials Institute	http://www.fdanews.com/rxti/rss/feed?rssId=22
General content from RxTi website.
Clinical Trials Advisor	http://www.fdanews.com/rss/feed?rssId=10
Clinical Trials Advisor is devoted to helping pharmaceutical manufacturers, clinical researchers, IRBs and investigators improve clinical trial operations and GCP compliance. You'll get the latest regulatory and international news, as well as practical advice for maximizing your clinical investments. No other resource provides such valuable reporting and training applicable to every area of clinical trials. From ethics to information technology, training to patient recruitment, accreditation to disclosure — if it impacts clinical trials, CTA covers it.
RxTrials Institute Drug Pipeline Alert	http://www.fdanews.com/rss/feed?rssId=8
Each Wednesday morning turn to the RxTrials Drug Pipeline Alert for the latest intelligence on the research and development of new drugs in high-cost therapeutic areas such as oncology/hematology, cardiovascular, pediatrics, respiratory and others. Weekly issues cover U.S. and international clinical trials, medical research, drug applications and co-development activities. Sign up today and receive your first issue of the Alert next Wednesday.

Terms and Conditions:

Please read this legal agreement carefully. By downloading an FDAnews RSS feed ("FDAnews feed") from FDAnews.com, you agree to be bound by the terms and conditions governing the use of our website as a whole ( http://www.fdanews.com/privacy), in addition to the terms and conditions below specifically governing your use of FDAnews feeds.

FDAnews feeds are intended solely for private, non-commercial use by individuals. Any other uses, including without limitation the distribution, sale or commercial exploitation of FDAnews feeds, in whole or in part, are strictly prohibited. FDAnews feeds are protected by the copyright laws of the United States and other countries. All individual articles, content and other elements comprising FDAnews feeds are copyrighted works.

For permission to publicly display, reproduce or distribute FDAnews feeds, including without limitation via a website or blog, please contact Alka Desai at adesai@fdanews.com . FDAnews is under no obligation to grant any permission request.

All legal rights in FDAnews feeds, including intellectual property rights, are the property of FDAnews.com and nothing in these terms grant you any legal rights in the feeds, including without limitation the right to make derivative uses of them. You acknowledge that FDAnews.com has absolute editorial control over the FDAnews feeds and you are forbidden to edit, alter or otherwise modify their content.

FDAnews feeds are available "as is." We do not warrant that FDAnews feeds will be error-free. There may be omissions, interruptions and inaccuracies in the content made available. We do not make any representations, nor do we endorse the accuracy, completeness, timeliness or reliability of any advice, opinion, statement or other content downloaded. Although we may take reasonable steps to prevent the introduction of viruses or other destructive materials that may be downloaded from via FDAnews feeds, we do not guarantee or warrant that FDAnews feeds will be free of such destructive features. Under no circumstances is FDAnews.com liable to you for any damages or harm arising from your use of FDAnews feeds. If you use or rely on FDAnews feeds, you do so exclusively at your own risk.

FDAnews.com reserves the right to modify or cease distribution of FDAnews feeds at any time, and reserves the right to require you to cease all use of its feeds at any time for any reason, including without limitation due to your failure to adhere to these terms and conditions. You hereby agree to indemnify, hold harmless and defend FDAnews.com with respect to all damages, losses, costs and expenses, including reasonable legal fees and litigation expenses, arising out of your use of FDAnews feeds and/or the breach of these terms and conditions.

FDAnews.com reserves the right to change the terms and conditions of use governing FDAnews feeds, or this website as a whole, at any time without notice. By continuing to use FDAnews.com or FDAnews feeds, you agree to be bound by any such changes.